Solanki

Savvy Soprano Sangeeta Kaur (Teresa Mai) releases pop-infused "Aurora"

Retrieved on: 
Tuesday, August 1, 2023
Boston, Berklee College of Music, Friends, Soprano, California State University, Hope, Human, Front and Center, Diplomatic mission, Starlight, The Recording Academy, Myth, Solanki, PBS, Grammy Awards, Film industry, Music

Grammy Award winning Soprano Sangeeta Kaur releases "Aurora," her sixth crossover album at Studio Hill in Austin, Texas.

Key Points: 
  • Grammy Award winning Soprano Sangeeta Kaur releases "Aurora," her sixth crossover album at Studio Hill in Austin, Texas.
  • "This album has characteristics of an Aurora," said Kaur.
  • The precision of the Soprano's gifted voice, coupled with her savvy production techniques, has carved out a large audience for the classically trained Kaur in the expanding crossover market.
  • "My life's mission is to create and share music that brings joy and positive transformation to the listener," says Kaur.

Eyenuk Secures the First European Union MDR Certification for Autonomous AI Detection of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma

Retrieved on: 
Tuesday, January 31, 2023
Regulation, Diabetes, AI, Diagnosis, Medical device, Certification, Severe cognitive impairment, European Commission, Ophthalmology, Diabetic retinopathy, EC, Risk, Glaucoma, CE, Retina, Solanki, MDR, AMD, Patient, Union, FDA, DR, Eye, IIB, EU

The EyeArt AI system was previously approved in the EU for the detection of DR including diabetic macular edema.

Key Points: 
  • The EyeArt AI system was previously approved in the EU for the detection of DR including diabetic macular edema.
  • This EC Certification makes the EyeArt AI system the first and only autonomous AI solution with Class IIb MDR CE marking for the automated detection of all three eye diseases and will allow Eyenuk customers in the EU to detect the diseases in a single exam using the same set of retinal images.
  • It reaffirms the strong results from rigorous clinical validation of the EyeArt AI system.”
    Kaushal Solanki, Chief Executive Officer and Founder of Eyenuk, commented, “This EC certification multiplies our impact in two ways.
  • First, our autonomous AI can now help many more patients at risk of vision loss – the population at risk of AMD and glaucoma, particularly seniors, in addition to people with diabetes.

Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology

Retrieved on: 
Monday, October 17, 2022
LinkedIn, Union, ESG, American Academy of Ophthalmology, AI, Accountability Act, Solution, Global health, Health Insurance Portability and Accountability Act, Adoption, Risk assessment, Twitter, Investment, Eye, Health Canada, IPE, Decision-making, Company, Food and Drug Administration, Diabetic retinopathy, General Data Protection Regulation, American Academy, CE, Biomarker, FDA, Glaucoma, NHS, CE marking, Risk, Government, Diagnosis, Stroke, HIPAA, CPT, NIH, Severe cognitive impairment, Technology, Board, Alzheimer's disease, PDF, Solanki, Patient, Diabetes, Business, Partnership, AXA, LOS, Food, Medicare, Doctor of Philosophy, GDPR, Medical device, Pharmaceutical industry, Health insurance, Ophthalmology, Infrastructure, Facebook

Eyenuk will use the capital to expand its AI product platform with additional disease indications and advanced care coordination, and to accelerate the platform's global commercialization and adoption.

Key Points: 
  • Eyenuk will use the capital to expand its AI product platform with additional disease indications and advanced care coordination, and to accelerate the platform's global commercialization and adoption.
  • Eyenuk's flagship EyeArt AI system has been more broadly adopted worldwide than any other autonomous AI technology for ophthalmology.
  • As part of the capital raise, Rob Binney has joined the Eyenuk Board of Directors as the Board's Chair.
  • It is designed to be General Data Protection Regulation (GDPR) and Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.

Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology

Retrieved on: 
Monday, October 17, 2022
LinkedIn, Union, ESG, American Academy of Ophthalmology, AI, Accountability Act, Solution, Global health, Health Insurance Portability and Accountability Act, Adoption, Risk assessment, Twitter, Investment, Eye, Health Canada, IPE, Decision-making, Company, Food and Drug Administration, Diabetic retinopathy, General Data Protection Regulation, American Academy, CE, Biomarker, FDA, Glaucoma, NHS, CE marking, Risk, Government, Diagnosis, Stroke, HIPAA, CPT, NIH, Severe cognitive impairment, Technology, Board, Alzheimer's disease, PDF, Solanki, Patient, Diabetes, Business, Partnership, AXA, LOS, Food, Medicare, Doctor of Philosophy, GDPR, Medical device, Pharmaceutical industry, Health insurance, Ophthalmology, Infrastructure, Facebook

Eyenuk will use the capital to expand its AI product platform with additional disease indications and advanced care coordination, and to accelerate the platform's global commercialization and adoption.

Key Points: 
  • Eyenuk will use the capital to expand its AI product platform with additional disease indications and advanced care coordination, and to accelerate the platform's global commercialization and adoption.
  • Eyenuk's flagship EyeArt AI system has been more broadly adopted worldwide than any other autonomous AI technology for ophthalmology.
  • As part of the capital raise, Rob Binney has joined the Eyenuk Board of Directors as the Board's Chair.
  • It is designed to be General Data Protection Regulation (GDPR) and Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.

Pizza Inn Brings House-Made All-Day Buffet to Small Town

Retrieved on: 
Thursday, May 19, 2022
Company, Buffalo, Solanki, Pie Five, RAVE, NASDAQ, Cheeseburger, Restaurant, Salad, Ciabatta Bacon Cheeseburger, Milk, NYXL, GLOBE, Hospitality industry, Fast food, Instagram, Pizza Inn, Pizza Inn

LINCOLNTON, N.C., May 19, 2022 (GLOBE NEWSWIRE) -- Pizza Inn , Americas Favorite Hometown Pizza Buffet, announced the opening of a new location in Lincolnton, North Carolina.

Key Points: 
  • LINCOLNTON, N.C., May 19, 2022 (GLOBE NEWSWIRE) -- Pizza Inn , Americas Favorite Hometown Pizza Buffet, announced the opening of a new location in Lincolnton, North Carolina.
  • Pizza Inn promises quality house-made food with every buffet experience and I look forward to growing its presence in our own community.
  • Were also excited to be one of the few Pizza Inn locations offering different beer selections as part of the all-day buffet.
  • Since 1958, Pizza Inn's popular pizza buffet, and friendly service have solidified the brand as America's hometown pizza place.